24 Followers USX:BNTX - BioNTech SE BioNTech SE
Sector: Health Care, Industry: Biotechnology
Add to Watchlist
   
Add Alert 


Yahoo Finance
Annual TTM
Balance Sheet Cash Flow Income Statement Key Ratios
Adjust Display Metrics

Graphs are exclusive for members only

Sign up for free to access most features of StocksCafe

Show %
2018 Q2 2018 Q3 2018 Q4 2019 Q1 2019 Q2 2019 Q3 2019 Q4 2020 Q1 2020 Q2 2020 Q3 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 Graph
Insider Holdings (%) [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 1.19%
0.1%
1.18%
-0.8%
66.88%
5587.2%
63.4%
-5.2%
62.87%
-0.8%
62.97%
0.2%
62.96%
0.0%
64.01%
1.7%
65.11%
1.7%
65.11%
0.0%
65.11%
0%
Net Margin [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 52.5%
-4.7%
52.75%
0.5%
57.23%
8.5%
58.02%
1.4%
52.31%
-9.9%
51.57%
-1.4%
53.26%
3.3%
39.33%
-26.2%
-113.54%
-
17.94%
-
30.96%
72.6%
Gross Margin [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 83.35%
-5.9%
80.1%
-3.9%
89.46%
11.7%
79.7%
-10.9%
76.08%
-4.5%
78.25%
2.9%
95.71%
22.3%
92.48%
-3.4%
2.86%
-96.9%
81.93%
2762.3%
87.89%
7.3%
Operating Margin [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 78.44%
-0.9%
74.88%
-4.5%
82.85%
10.6%
73.65%
-11.1%
60.14%
-18.4%
64.17%
6.7%
80.93%
26.1%
57.09%
-29.5%
-300.95%
-
9.15%
-
40.43%
342.0%
Total Revenue [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 5.29B
158.3%
6.09B
15.1%
5.53B
-9.1%
6.37B
15.2%
3.2B
-49.9%
3.46B
8.3%
4.28B
23.6%
1.28B
-70.2%
167.7M
-86.9%
895.3M
433.9%
1.48B
65.2%
Total Assets [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 9.12B
116.8%
14.23B
56.1%
15.83B
11.2%
20.3B
28.2%
21.16B
4.2%
22.66B
7.1%
23.28B
2.7%
22.08B
-5.2%
22.23B
0.7%
22.21B
-0.1%
23.01B
3.6%
Total Liabilities [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 3.65B
116.8%
5.52B
51.1%
3.94B
-28.7%
4.39B
11.5%
4.32B
-1.5%
4.29B
-0.7%
3.22B
-24.9%
1.81B
-43.7%
2.32B
27.9%
2.34B
0.9%
2.76B
17.9%
Total Equity [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 5.46B
116.9%
8.71B
59.5%
11.89B
36.5%
15.91B
33.8%
16.83B
5.8%
18.37B
9.1%
20.06B
9.2%
20.27B
1.0%
19.91B
-1.8%
19.87B
-0.2%
20.25B
1.9%
Operating CashFlow [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] -99.93M
-
1.5B
-
-199.5M
-
4.05B
-
3.92B
-3.2%
4.78B
21.9%
829.2M
-82.6%
-677.4M
-
4.39B
-
811.2M
-81.5%
850.9M
4.9%
Beginning Cash Position [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 888.22M
-26.6%
913.99M
2.9%
2.03B
121.6%
1.69B
-16.4%
6.16B
264.2%
9.33B
51.4%
13.42B
43.8%
13.88B
3.4%
12.14B
-12.5%
14.17B
16.7%
13.5B
-4.7%
End Cash Position [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 910.74M
2.2%
2.03B
122.4%
1.69B
-16.4%
6.16B
264.2%
9.33B
51.4%
13.42B
43.8%
13.88B
3.4%
12.14B
-12.5%
14.17B
16.7%
13.5B
-4.7%
11.66B
-13.6%
Free Cash Flow [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] -129.92M
-
1.46B
-
-252.9M
-
3.99B
-
3.84B
-3.7%
4.7B
22.2%
684.7M
-85.4%
-732.2M
-
4.08B
-
660M
-83.8%
660.7M
0.1%
Net Income (Cont Operations) [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 4.01B
144.1%
4.67B
16.4%
4.71B
1.0%
5.02B
6.5%
2.32B
-53.8%
2.44B
5.4%
3.17B
29.8%
707.7M
-77.7%
-412.2M
-
227.4M
-
663.2M
191.6%
Diluted Net Income [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 2.78B
146.2%
3.21B
15.6%
3.17B
-1.4%
3.7B
16.8%
1.67B
-54.8%
1.78B
6.8%
2.28B
27.7%
502.2M
-78.0%
-190.4M
-
160.6M
-
457.9M
185.1%
Diluted EPS [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 10.73
144.5%
12.349
15.1%
12.17
-1.4%
14.24
17.0%
6.45
-54.7%
6.98
8.2%
9.26
32.7%
2.05
-77.9%
-0.79
-
0.67
-
1.89
182.1%
Return On Equity (%) [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 69.66%
20.1%
45.24%
-35.1%
30.73%
-32.1%
26.61%
-13.4%
10.21%
-61.6%
10.14%
-0.7%
11.86%
17.0%
2.49%
-79.0%
-0.95%
-
0.81%
-
2.28%
182.7%
Return On Assets (%) [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 41.74%
20.7%
27.47%
-34.2%
21.06%
-23.3%
20.47%
-2.8%
8.07%
-60.6%
8.15%
1.0%
9.92%
21.8%
2.21%
-77.7%
-0.86%
-
0.72%
-
2.03%
180.2%
Values are in EUR whenever applicable | Fiscal year ends on December 31
Powered by Morningstar

Your Holdings
Dashboard
Portfolio
Options

Tools
Screener
Watchlist
Alerts
Notes
Community
Forum
Blog
YouTube
Shared Portfolios
Shared Screeners

Collab with Brokerages
Moomoo x StocksCafe
Tiger x StocksCafe

Help
Quickstart Guides
StocksCafe Academy
StocksCafe Youtube Channel

About StocksCafe
Our Story
Send Feedback
Pricing
Market
Singapore
Hong Kong
Tokyo
Kuala Lumpur
United States
London
Shenzhen
Shanghai
Bombay
National (India)
Indexes
Singapore Savings Bonds
Singapore T-Bills
CoinGecko
Your Account
Settings
Subscriptions
Referrals
Messages
Profile
YouTube
Server T1

About · FAQs · StocksCafe © 2024 · Privacy · Terms